Daily Management Review

AstraZeneca & Ironwood In An Agreement On Zurampic Right


04/28/2016


The two pharmacists have arrived at an agreement whereby, they will support each other in developing gout treatment.



AstraZeneca has entered in a “licensing agreement” with the “Ironwood Pharmaceuticals” on the issue of “exclusive US rights to Zurampic”. The latter is used for treating “hyperuricemia” which results in “uncontrolled gout” problem.
 
The exclusive U.S. rights on Zurampic will be acquires by Ironwood for using the same in a “fixed-dose combination” which will involve “lesinurad and allopurinol”.
 
Moreover, AstraZeneca informed that it has plans of submitting the combination of the fixed dose to regulatory authorities for reviewing in the latter half of the year 2016, while Ironwood will make a payment to AstraZeneca for sales and other “milestone” related issues. The amount that will be paid by Ironwood to AstraZeneca is “$265m” in addition to “single-digit royalties on product sales”.
 
On the other hand, AstraZeneca will be manufacturing Zurampic and supply the same to Ironwood besides supporting some of Ironwood’s services. Furthermore, AstraZeneca will also be undertaking the “FDA post-approval commitment” on behalf of Ironwood.
 
 
References:
http://www.digitallook.com/







Science & Technology

Facebook may start production of its own microprocessors

Long-Term Alcohol Monitoring Could Be Possible With A New Injectable Chip Developed By U.S. Researchers

Sweden Now Has The First Electrified Road In The World

Over 270,000 Account Globally Banned From Twitter For Promotion Of Terrorism

Device Capable Of Hearing The Inner Voice Developed By Researchers

New mobile technologies will warn about natural disasters

The brewing industry welcomes blockchain

Asset-Sharing App Of Ryder Is Meant For Commercial Vehicles

Credit Suisse: China will become the leader in AI sphere

Five new technologies that will change the world

World Politics

World & Politics

Debates over Google are heating as a new EU directive is about to be introduced

Will Merkel accept Macron's plans for Europe?

USA and China are pushing North Korea to denuclearization

Germany's dilemma: Will the atomic energy win?

A Forceful Response To Syria Attack Will Be Given By U.S.: Trump

Is Trump’s Maximum Pressure Tactic On North Korea Succeeding Because Of China?

Why are Turkey-EU relations moving back?

Record-Breaking $39 Million raised for Rare Cancer Research in 2018 by Cycle for Survival